Search

Your search keyword '"Timsit, J.F."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Timsit, J.F." Remove constraint Author: "Timsit, J.F."
157 results on '"Timsit, J.F."'

Search Results

1. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

2. Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets

4. Should We Perform an Immediate Coronary Angiogram in All Patients After Cardiac Arrest?: Insights From a Large French Registry

6. Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness

11. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

13. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

15. Prise en charge des exacerbations de BPCO en unité de soins intensifs : tendances et résultats issus du réseau OUTCOMEREA, 1997–2018

21. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

26. Glucocorticoides associés à une faible dose d’anti-IL1 (Anakinra) pour les COVID-19 sévères hors réanimation une étude de cohorte

29. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

30. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

31. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

32. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

33. The quality of studies evaluating antimicrobial stewardship interventions: a systematic review

34. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

35. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

38. Évolution du taux de réponse à la chimiothérapie et de la survie des patients atteints d’un cancer bronchique à petites cellules au CHU Grenoble-Alpes entre 1997 et 2017

42. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

43. Should We Perform an Immediate Coronary Angiogram in All Patients After Cardiac Arrest?

44. Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France

45. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

46. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

47. Task force on management and prevention of Acinetobacter baumannii infections in the ICU

48. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

Catalog

Books, media, physical & digital resources